A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Lawrence J. Solin, Robert P. Gray, Frederick L. Baehner, +13

JNCI Journal of the National Cancer Institute

Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831

Patrick C. Roche, VJ Suman, Robert B. Jenkins, +7

JNCI Journal of the National Cancer Institute

Metaplastic breast cancer: Prognosis and response to systemic therapy

Daniel Rayson, Alex A. Adjei, Vera J. Suman, +2

Annals of Oncology

Surgical OncologyBreast OncologyMedicinePathologyBreast Cancer +3

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer

J-AW Chapman, D. Meng, L. E. Shepherd, +6

JNCI Journal of the National Cancer Institute

American society of clinical oncology 2003 update on the role of biophosphonates and bone health issues in women with breast cancer

Bruce E. Hillner, J. N. Ingle, Rowan T. Chlebowski, +1

Breast Diseases A Year Book Quarterly

Bone DiseaseBreast OncologyBone HealthOncologyClinical Oncology 2003 +9

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

Paul E. Goss, J. N. Ingle, Silvana Martino, +11

Annals of Oncology

Breast OncologyOncologyClinical TrialsGynecologyBreast Cancer +8

Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer

Paul E. Goss, J. N. Ingle, Silvana Martino, +7

Journal of Clinical Oncology

Breast OncologyCancer ManagementGynecologyPharmacotherapyOrthopaedic Surgery +21

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

J. N. Ingle, Dongsheng Tu, Joseph L. Pater, +15

Annals of Oncology

Breast OncologyOncologyEarly Breast CancerPharmacologyClinical Trials +8

Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer.

J. N. Ingle, Vera J. Suman, Patricia Johnson, +7

PubMed

Metastatic Breast CancerOncologyBreast OncologyMedicineGynecology +12

Uranium Dust Exposure and Lung Cancer Risk in Four Uranium Processing Operations

Elizabeth A. Dupree, Janice P. Watkins, J. N. Ingle, +3

Epidemiology

Nuclear Waste ManagementUranium Dust ExposureRadioactive ContaminationRadiation ExposureLung Cancer Risk +17